Notice for mitotane (Asteri Pharma Pty Ltd)
Active ingredients
mitotane
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
tablet
Indication
Treatment of Adrenocortical Carcinoma (ACC)
Therapeutic area
Oncology